Strs Ohio Landos Biopharma, Inc. Transaction History

Strs Ohio

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	SELL	$0.6 - $1.5 $6,840 - $17,100	-11,400 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$9.77 - $15.77 $96,723 - $156,123	9,900 Added 660.0%	11,400 $166,000
Q1 2021 Apr 23, 2021	BUY	$9.47 - $16.26 $14,205 - $24,390	1,500 New	1,500 $14,000

Ticker LABP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,254,900
Description
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.